Evidence map›Paper›PMID 32976538›Full record

ArticlePLoS neglected tropical diseases2020

A single mutation (V64G) within the RING Domain of Z attenuates Junin virus.

Steven J Hallam, John T Manning, Junki Maruyama, Alexey Seregin, Cheng Huang, David H Walker, Juan Carlos de la Torre, Slobodan Paessler

Open access · goldAbstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.2field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Steven J HallamDepartment of Pathology, University of Texas Medical Branch, Galveston, Texas, United States of America.
John T ManningDepartment of Pathology, University of Texas Medical Branch, Galveston, Texas, United States of America.
Junki MaruyamaDepartment of Pathology, University of Texas Medical Branch, Galveston, Texas, United States of America.ORCID 0000-0003-0088-4793
Alexey SereginDepartment of Pathology, University of Texas Medical Branch, Galveston, Texas, United States of America.
Cheng HuangDepartment of Pathology, University of Texas Medical Branch, Galveston, Texas, United States of America.ORCID 0000-0001-5402-353X
David H WalkerDepartment of Pathology, University of Texas Medical Branch, Galveston, Texas, United States of America.
Juan Carlos de la TorreDepartment of Immunology and Microbial Science, Scripps University, La Jolla, California, United States of America.ORCID 0000-0002-8171-8115
Slobodan PaesslerDepartment of Pathology, University of Texas Medical Branch, Galveston, Texas, United States of America.ORCID 0000-0002-2213-9551
The University of Texas Medical Branch at Galveston · USScripps Research Institute · US

Funding

Recombinant life attenuated vaccine against Argentine hemorrhagic feverR01AI093445 · NIAID · UNIVERSITY OF TEXAS MED BR GALVESTON · PI DE LA TORRE, JUAN C., PAESSLER, SLOBODAN · 2011 to 2015
$4.6M
NIAID NIH HHS R01 AI093445
6 · The paper itself

Abstract

Junin virus (JUNV) is a New World arenavirus that is the causative agent of Argentine hemorrhagic fever (AHF). Candid#1 (Can) is a live-attenuated vaccine strain of JUNV that since its introduction has resulted in a marked decrease in AHF incidence within the endemic regions of the Pampas in Argentina. Originally, the viral determinants and mechanisms of Can attenuation were not well understood. Recent work has identified the glycoprotein as the major attenuating factor for Can. The establishment of attenuating strategies based on any of the other viral proteins, however, has not been pursued. Here, we document the role of Can Z resulting in incompatibilities with wild type JUNV that results in decreased growth in vitro. In addition, this incompatibility results in attenuation of the virus in the guinea pig model. Further, we identify a single mutation (V64G) in the Z protein that is able to confer this demonstrated attenuation. By establishing and characterizing a novel attenuation strategy for New World mammarenaviruses, we hope to aid future vaccine development for related emerging pathogens including Machupo virus (MACV), Guanarito virus (GTOV), and Sabia virus (SABV).

Indexed as

MutationAnimalsCell LineChlorocebus aethiopsCricetinaeFemaleGlycoproteinsGuinea PigsHemorrhagic Fever, AmericanJunin virusVero CellsViral ProteinsGlycoproteinsViral Proteins

Identifiers

PMID32976538
PMCPMC7540883
OpenAlexW3088528313

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.